Share chart Phathom Pharmaceuticals, Inc.
Extended chart
Simple chart
About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals Inc (Phathom Pharmaceuticals) — биофармацевтическая компания, занимающаяся разработкой и коммерциализацией лекарственных средств для лечения заболеваний желудочно-кишечного тракта (ЖКТ). Компания предлагает линейку продуктов, включающую вонопразан, пероральный низкомолекулярный блокатор калия, конкурирующий с кислотой (P-CAB). Он также оценивает его вонопразан в сочетании с антибиотиками для лечения инфекции Helicobacter pylori. more details| IPO date | 2019-10-25 |
|---|---|
| ISIN | US71722W1071 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.phathompharma.com |
| Цена ао | 6.42 |
| Change price per day: | 0% (4.88) |
|---|---|
| Change price per week: | +0.2053% (4.87) |
| Change price per month: | +15.64% (4.22) |
| Change price per 3 month: | -26.28% (6.62) |
| Change price per half year: | -68.84% (15.66) |
| Change price per year: | -51.3% (10.02) |
| Change price per 3 year: | -65.97% (14.34) |
| Change price per 5 year: | -81.85% (26.88) |
| Change price per year to date: | -38.92% (7.99) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Frazier Life Sciences Management, L.P. | 10109279 | 17.29 |
| Medicxi Ventures Management (Jersey) Ltd | 3760869 | 6.43 |
| Carlyle Group Inc. | 3496808 | 5.98 |
| Invesco Ltd. | 3167653 | 5.42 |
| Blackrock Inc. | 2678891 | 4.58 |
| Ensign Peak Advisors, Inc | 2280000 | 3.9 |
| NEA Management Company, LLC | 1960169 | 3.35 |
| Vanguard Group Inc | 1956429 | 3.35 |
| Avidity Partners Management, LP | 1721580 | 2.94 |
| Gilder, Gagnon, Howe & Co. | 1455132 | 2.49 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Future Tech ETF | 0.12211 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 0.12211 | 618.5 | 0.8416 |
| iShares Morningstar Small-Cap ETF | 0.01336 | 391.25 | 1.60498 |
| 0.08 | 478.7 | 1.09 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Terrie J. Curran | President, CEO & Director | 1.11M | 1969 (56 years) |
| Mr. David A. Socks | Co-Founder & Director | 58.78k | 1975 (50 years) |
| Dr. Azmi Nabulsi M.D., M.P.H. | Co-Founder & COO | 815.21k | 1960 (65 years) |
| Ms. Molly Henderson CPA, MBA | Chief Financial & Business Officer | 671.27k | 1971 (54 years) |
| Mr. Tom Harris | Chief Development Sciences Officer | N/A | |
| Dr. Eckhard Leifke M.D., Ph.D. | Chief Medical Officer | N/A | |
| Dr. Aditya Kohli Ph.D. | Co-Founder | 319.65k | 1988 (37 years) |
| Mr. Martin J. Gilligan | Chief Commercial Officer | N/A | |
| Mr. Paul Cocja | Chief People Officer |
Address: United States, Florham Park. NJ, 100 Campus Drive - open in Google maps, open in Yandex maps
Website: https://www.phathompharma.com
Website: https://www.phathompharma.com
